Hitachi reclaims Summit gamma cameras
Hitachi Medical of Tokyo will use the RSNA meeting as a springboardin its plan to reenter the nuclear medicine market with directsales and marketing of digital gamma cameras it has manufacturedfor Summit Nuclear. Hitachi will describe the products as
Hitachi Medical of Tokyo will use the RSNA meeting as a springboardin its plan to reenter the nuclear medicine market with directsales and marketing of digital gamma cameras it has manufacturedfor Summit Nuclear. Hitachi will describe the products as works-in-progresson panels in its RSNA booth (SCAN 10/11/95).
Hitachi manufactured the single-head 1024RZ and the dual-headT-22 for Summit, which this year merged with Sopha Medical toform SMV (SCAN 6/21/95). SMV decided to deemphasize the Hitachi-madecameras in favor of systems of its own design.
Hitachi has updated the 1024RZ and T-22 cameras and is resubmittinga 510(k) application for them under the trade name SPECTRADigital.Hitachi is also planning to develop a digital variable-angle dual-headgamma camera for release next year.
In MRI, Hitachi will highlight enhancements to its Airis andStratis platforms, introduced at last year's meeting. A new softwarerelease for the open-configuration Airis and the MRP-7000 0.3-teslaconventional magnet will enable the use of new fast scanning andMR angiography packages. On the 1.5-tesla Stratis, Hitachi willshow phased-array coils and multishot echo-planar imaging as works-in-progress.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
